Case and Research Letter
Sevoflurane: A Valid Alternative for the Treatment of Vascular Ulcers?
Sevoflurano, ¿una alternativa en el tratamiento de las úlceras vasculares?
Read
8229
Timeswas read the article
2662
Total PDF
5567
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 6 | 12 | 1 | 13 |
| 2025 5 | 126 | 35 | 161 |
| 2025 4 | 195 | 24 | 219 |
| 2025 3 | 162 | 26 | 188 |
| 2025 2 | 156 | 34 | 190 |
| 2025 1 | 82 | 24 | 106 |
| 2024 12 | 94 | 22 | 116 |
| 2024 11 | 114 | 61 | 175 |
| 2024 10 | 72 | 49 | 121 |
| 2024 9 | 66 | 27 | 93 |
| 2024 8 | 89 | 63 | 152 |
| 2024 7 | 84 | 31 | 115 |
| 2024 6 | 77 | 35 | 112 |
| 2024 5 | 77 | 51 | 128 |
| 2024 4 | 77 | 24 | 101 |
| 2024 3 | 68 | 20 | 88 |
| 2024 2 | 64 | 27 | 91 |
| 2024 1 | 58 | 34 | 92 |
| 2023 12 | 60 | 14 | 74 |
| 2023 11 | 78 | 34 | 112 |
| 2023 10 | 79 | 21 | 100 |
| 2023 9 | 84 | 27 | 111 |
| 2023 8 | 53 | 18 | 71 |
| 2023 7 | 50 | 32 | 82 |
| 2023 6 | 52 | 23 | 75 |
| 2023 5 | 54 | 27 | 81 |
| 2023 4 | 52 | 26 | 78 |
| 2023 3 | 54 | 21 | 75 |
| 2023 2 | 47 | 24 | 71 |
| 2023 1 | 52 | 32 | 84 |
| 2022 12 | 53 | 69 | 122 |
| 2022 11 | 28 | 32 | 60 |
| 2022 10 | 38 | 29 | 67 |
| 2022 9 | 45 | 42 | 87 |
| 2022 8 | 88 | 34 | 122 |
| 2022 7 | 35 | 45 | 80 |
| 2022 6 | 33 | 38 | 71 |
| 2022 5 | 72 | 39 | 111 |
| 2022 4 | 63 | 36 | 99 |
| 2022 3 | 53 | 46 | 99 |
| 2022 2 | 40 | 35 | 75 |
| 2022 1 | 72 | 34 | 106 |
| 2021 12 | 37 | 39 | 76 |
| 2021 11 | 46 | 42 | 88 |
| 2021 10 | 49 | 66 | 115 |
| 2021 9 | 41 | 44 | 85 |
| 2021 8 | 38 | 40 | 78 |
| 2021 7 | 35 | 32 | 67 |
| 2021 6 | 39 | 36 | 75 |
| 2021 5 | 33 | 34 | 67 |
| 2021 4 | 93 | 42 | 135 |
| 2021 3 | 95 | 30 | 125 |
| 2021 2 | 81 | 31 | 112 |
| 2021 1 | 56 | 27 | 83 |
| 2020 12 | 65 | 11 | 76 |
| 2020 11 | 35 | 20 | 55 |
| 2020 10 | 49 | 16 | 65 |
| 2020 9 | 50 | 18 | 68 |
| 2020 8 | 44 | 19 | 63 |
| 2020 7 | 38 | 18 | 56 |
| 2020 6 | 60 | 42 | 102 |
| 2020 5 | 52 | 18 | 70 |
| 2020 4 | 40 | 17 | 57 |
| 2020 3 | 50 | 16 | 66 |
| 2020 2 | 10 | 0 | 10 |
| 2019 12 | 8 | 8 | 16 |
| 2019 11 | 4 | 7 | 11 |
| 2019 10 | 0 | 7 | 7 |
| 2019 9 | 4 | 13 | 17 |
| 2019 8 | 4 | 11 | 15 |
| 2019 7 | 8 | 11 | 19 |
| 2019 6 | 2 | 17 | 19 |
| 2019 5 | 6 | 27 | 33 |
| 2019 4 | 2 | 17 | 19 |
| 2019 3 | 0 | 10 | 10 |
| 2019 2 | 4 | 9 | 13 |
| 2019 1 | 0 | 1 | 1 |
| 2018 12 | 1 | 3 | 4 |
| 2018 11 | 3 | 8 | 11 |
| 2018 10 | 2 | 0 | 2 |
| 2018 3 | 0 | 1 | 1 |
| 2018 2 | 36 | 7 | 43 |
| 2018 1 | 35 | 6 | 41 |
| 2017 12 | 40 | 7 | 47 |
| 2017 11 | 26 | 10 | 36 |
| 2017 10 | 38 | 10 | 48 |
| 2017 9 | 35 | 26 | 61 |
| 2017 8 | 28 | 14 | 42 |
| 2017 7 | 21 | 12 | 33 |
| 2017 6 | 47 | 17 | 64 |
| 2017 5 | 30 | 20 | 50 |
| 2017 4 | 26 | 28 | 54 |
| 2017 3 | 27 | 28 | 55 |
| 2017 2 | 20 | 13 | 33 |
| 2017 1 | 22 | 15 | 37 |
| 2016 12 | 31 | 16 | 47 |
| 2016 11 | 53 | 16 | 69 |
| 2016 10 | 59 | 21 | 80 |
| 2016 9 | 49 | 18 | 67 |
| 2016 8 | 50 | 10 | 60 |
| 2016 7 | 48 | 12 | 60 |
| 2016 6 | 16 | 8 | 24 |
| 2016 5 | 8 | 11 | 19 |
| 2016 4 | 2 | 14 | 16 |
| 2016 3 | 3 | 1 | 4 |
| 2016 2 | 14 | 1 | 15 |
| 2016 1 | 11 | 3 | 14 |
| 2015 12 | 12 | 1 | 13 |
| 2015 11 | 7 | 4 | 11 |
| 2015 10 | 11 | 12 | 23 |
| 2015 9 | 8 | 7 | 15 |
| 2015 8 | 10 | 4 | 14 |
| 2015 7 | 30 | 7 | 37 |
| 2015 6 | 33 | 12 | 45 |
| 2015 5 | 51 | 18 | 69 |
| 2015 4 | 28 | 7 | 35 |
| 2015 3 | 33 | 4 | 37 |
| 2015 2 | 28 | 4 | 32 |
| 2015 1 | 40 | 4 | 44 |
| 2014 12 | 30 | 6 | 36 |
| 2014 11 | 20 | 4 | 24 |
| 2014 10 | 41 | 4 | 45 |
| 2014 9 | 31 | 2 | 33 |
| 2014 8 | 20 | 6 | 26 |
| 2014 7 | 20 | 4 | 24 |
| 2014 6 | 26 | 6 | 32 |
| 2014 5 | 37 | 12 | 49 |
| 2014 4 | 76 | 8 | 84 |
| 2014 3 | 8 | 8 | 16 |
Show all
